Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 3, 2002, Pages 400-404

  Kenagy, Richard D ^a   Fischer, Jens W ^a   Davies, Mark G ^a   Berceli, Scott A ^a   Hawkins, Suzanne M ^a   Wight, Thomas N ^a   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Flow; Intimal atrophy; Plasminogen; Proteoglycan; Smooth muscle cells; Urokinase

Indexed keywords

BATIMASTAT; GELATINASE A; GELATINASE B; METHIONINE; PLASMIN; PLASMIN INHIBITOR; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; POLITEF; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SULFUR 35; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UROKINASE; VERSICAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; BABOON; CONTROLLED STUDY; GRAFT FAILURE; ILIAC ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ATROPHY; BLOOD VESSEL PROSTHESIS; ILIAC ARTERY; LECTINS, C-TYPE; MALE; MATRIX METALLOPROTEINASES; PAPIO; PERIPHERAL VASCULAR DISEASES; PLASMIN; PLASMINOGEN ACTIVATORS; POLYTETRAFLUOROETHYLENE; PROTEASE INHIBITORS; PROTEOCHONDROITIN SULFATES; REGIONAL BLOOD FLOW; SERINE ENDOPEPTIDASES; TUNICA INTIMA; URINARY PLASMINOGEN ACTIVATOR; VERSICANS;

EID: 0036124632     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0302.105376     Document Type: Article

References (38)

1. Shear stress, the endothelium and the balance between flow-induced contraction and dilation in animals and man
2. Blood flow-induced remodeling of the artery wall
3. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis
4. Relationship between neointimal thickness and shear stress after wall stent implantation in human coronary arteries
5. Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts
6. Acute reductions in blood flow and shear stress induce platelet-derived growth factor-A expression in baboon prosthetic grafts
7. Time course of flow-induced smooth muscle cell proliferation and intimal thickening in endothelialized baboon vascular grafts
8. Increased blood flow induces regression of intimal hyperplasia
9. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9
10. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery
11. Effects of platelet-derived growth factor and transforming growth factor-beta1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells
12. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells
13. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme
14. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
15. Plasminogen is a critical determinant of vascular remodeling in mice
16. Extracellular matrix remodeling by metalloproteinases and plasminogen activators
17. Extrahepatic synthesis of plasminogen in the human cornea is up-regulated by interleukins-1 α and -1β
18. The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration
19. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells-inhibitor neutralization and one-step affinity purification
20. Matrix plasminogen activator inhibitor: Modulation of the extracellular proteolytic environment
21. Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro: Effect of active site mutagenized tissue-type plasminogen activator
22. The cleavage and inactivation of plasminogen activator inhibitor type 1 and α2-antiplasmin by reptilase, a thrombin-like venom enzyme
23. 442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4
24. Glial hyaluronate-binding protein: A product of metalloproteinase digestion of versican?
25. The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema
26. Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456
27. Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: A study in the atherosclerotic Yucatan micropig
28. Expression of plasminogen-related gene B varies among normal tissues and increases in cancer tissues
29. Plasminogen has a broad extrahepatic distribution
30. Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues
31. Loss of cell viability dramatically elevates cell surface plasminogen binding and activation
32. Terminal differentiation of cultured human epidermal cells
33. The role of an enolase-related molecule in plasminogen binding to cells
34. The macrophage and fibrinolysis
35. Endoluminal arterial injury in plasminogen-deficient mice
36. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis
37. Plasmin and matrix metalloproteinases in vascular remodeling
38. Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes